Patents by Inventor Todd Robert Klaenhammer

Todd Robert Klaenhammer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8492124
    Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
    Type: Grant
    Filed: February 17, 2010
    Date of Patent: July 23, 2013
    Assignee: Ritter Pharmaceuticals, Inc.
    Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Robert Klaenhammer
  • Publication number: 20100215738
    Abstract: The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a prebiotic composition, optionally in combination with effective amount of a probiotic microbe or microbes.
    Type: Application
    Filed: February 17, 2010
    Publication date: August 26, 2010
    Applicant: Ritter Pharmaceuticals, Inc.
    Inventors: Andrew J. Ritter, Dennis Savaiano, David Barnes, Todd Robert Klaenhammer
  • Publication number: 20040091922
    Abstract: The present invention provides isolated &bgr;-Glucuronidase (GUS) having activity at acidic pH and nucleic acids encoding the same. The nucleic acids may be isolated from any suitable species, and in a preferable embodiment are isolated from Lactobacillus gasseri.
    Type: Application
    Filed: September 30, 2003
    Publication date: May 13, 2004
    Inventors: William Michael Russell, Todd Robert Klaenhammer
  • Patent number: 6686192
    Abstract: Recombinant bacteria containing nucleotide sequences encoding Streptococcus thermophilus phage helicase and primase genes expressed in the antisense orientation and methods of making and using the same are disclosed. Replication of bacteriophage infecting this bacterial cell, can be inhibited or decreased by constitutively expressing, the antisense oligonucleotide encoding for S. thermophilus phage helicase or primase.
    Type: Grant
    Filed: August 21, 2000
    Date of Patent: February 3, 2004
    Assignee: North Carolina State University
    Inventors: Joseph Miland Sturino, Todd Robert Klaenhammer
  • Patent number: 6664097
    Abstract: The present invention provides isolated &bgr;-Glucuronidase (GUS) having activity at acidic pH and nucleic acids encoding the same. The nucleic acids may be isolated from any suitable species, and in a preferable embodiment are isolated from Lactobacillus gasseri.
    Type: Grant
    Filed: May 21, 2001
    Date of Patent: December 16, 2003
    Assignee: North Carolina State University
    Inventors: William Michael Russell, Todd Robert Klaenhammer
  • Publication number: 20030003562
    Abstract: The present invention provides isolated &bgr;-Glucuronidase (GUS) having activity at acidic pH and nucleic acids encoding the same. The nucleic acids may be isolated from any suitable species, and in a preferable embodiment are isolated from Lactobacillus gasseri.
    Type: Application
    Filed: May 21, 2001
    Publication date: January 2, 2003
    Inventors: William Michael Russell, Todd Robert Klaenhammer